This population, either injured workers under workers’ compensation or personal-injury claimants, faces distinct drivers of delayed recovery, including secondary gain concerns, litigation, workplace psychosocial factors, fear-avoidance beliefs, and system-level incentives that can prolong disability. Guidelines from the American College of Occupational and Environmental Medicine (ACOEM), state workers’ compensation medical treatment guidelines (e.g., New York, California), the 2022 Centers for Disease Control and Prevention (CDC) Clinical Practice Guideline for Prescribing Opioids, and physical-therapy clinical practice guidelines consistently emphasize these distinctions.

A fellowship-trained pain specialist with strong musculoskeletal knowledge holds a clear evaluative advantage in this population. Such specialists are uniquely positioned to integrate detailed pain pathophysiology, precise musculoskeletal examination, imaging correlation, and functional assessment. This expertise enables more accurate differentiation of nociceptive, neuropathic, and nociplastic pain mechanisms; identification of red-flag or treatable structural drivers; and recognition of psychosocial amplifiers that commonly prolong disability after injury. Their training supports higher-fidelity determination of work capacity, appropriate interventional pain options or rehabilitative options, and avoidance of treatments that risk iatrogenic harm or delayed recovery.

Documentation requirements

Documentation must be more detailed, objective, and functionally oriented than in general practice because records serve dual medical and medico-legal purposes (claims adjudication, authorization of care, and return-to-work decisions). Key elements recommended by ACOEM and occupational-medicine best-practice statements include:

• Mechanism and causation: Precise description of the injury event (the “four W’s”: where, when, who, what), temporal relationship to work exposures, job demands, protective equipment use, and a clear cause-and-effect analysis that matches the mechanism of injury to the specific impairments documented on examination and testing. Establishing this causal linkage is essential for validating the relationship between the claimed event and the observed functional deficits.
• Functional impact: Baseline and serial assessment of work capacity, activities of daily living, specific limitations (e.g., lifting, positional tolerances, endurance), and validated tools (Work Ability Index, DASH work subscale, Oswestry, PEG scale). Subjective pain scores alone are insufficient; objective functional gains (range of motion, strength, task performance, return from modified to full duty) must be documented.
• Disability risk factors: Screening for psychosocial predictors of prolonged disability (fear-avoidance, catastrophizing, low recovery expectations, depression/anxiety, perceived injustice, litigation involvement). Physical examination findings of pain behavior are also recorded.
• Treatment rationale and response: Every intervention is tied to measurable functional goals. Continued treatment requires evidence of objective improvement; passive modalities or medications without functional progress are not supported.
• Work status and restrictions: Explicit statements of abilities, restrictions, and limitations at every visit, plus communication with the employer when appropriate.

Failure to document these elements, and in particular failure to match the cause-and-effect analysis linking mechanism to impairment, can delay care authorization, prolong disability, and expose providers to audit or medicolegal risk.

Unique features of this population and differentiated approach

Compared with the general population seeking care for similar musculoskeletal pain, injured workers and personal-injury patients show higher rates of delayed recovery, chronic pain, and work disability even when tissue pathology is comparable. Contributing factors include involvement in a compensation or litigation system, higher prevalence of psychosocial barriers, potential for secondary gain, and occupational physical demands that must be matched to residual capacity. Consequently, management diverges from standard primary-care or pain-clinic approaches in several evidence-based ways:

• Function over pure analgesia: The primary goal is restoration of work capacity and prior functional status, not elimination of pain. Pain is treated as a barrier to function rather than the sole target. Patients are educated that residual pain does not equate to ongoing tissue damage and that early graded activity is safe and therapeutic.
• Active, time-limited, goal-oriented care: Emphasis is placed on active exercise, work-task simulation, graded activity, and self-management rather than prolonged passive modalities, repeated imaging, or open-ended opioid therapy. ACOEM and state guidelines recommend early physical or occupational therapy with specific exercise prescriptions, activity modification, and short courses of NSAIDs or acetaminophen. Opioids, when used at all, are limited to the lowest effective dose for the shortest duration (typically 3-5 days for acute severe injury) because they are linked to prolonged disability, and interventional pain procedures can be used as a facilitator for functional recovery.
• Early return-to-work focus: Prolonged absence itself is a risk factor for chronic disability. Evidence shows that patients returned to modified or full duty early have superior short- and long-term outcomes. Treatment plans therefore incorporate transitional work, job-site modifications, and progressive loading matched to job demands. Multidisciplinary evaluation is indicated by 6-8 weeks if recovery is delayed.
• Biopsychosocial and psychologically informed care: Screening and treatment of psychosocial factors occur earlier and more systematically. Cognitive-behavioral strategies, motivational interviewing, education on pain neuroscience, and, when indicated, formal psychological evaluation are integrated. Functional restoration or interdisciplinary programs may be considered for selected patients who have failed conservative care and remain significantly disabled, provided clear functional and return-to-work goals are defined.
• Avoidance of interventions that prolong disability: Unnecessary imaging, prolonged rest, immobilization, and open-ended passive therapies are discouraged because they reinforce the sick role and delay recovery.

Justification for pain procedures in workers’ compensation and personal injury cases

In workers’ compensation and personal-injury cases, interventional pain procedures are medically justified when a fellowship-trained pain specialist with musculoskeletal expertise has first established a clear cause-and-effect relationship between the documented injury mechanism and the specific impairment, and when the patient has failed an appropriate course of conservative, active care yet remains functionally limited in a manner that impedes return to work or prior status. Under these conditions, procedures (such as targeted injections or other evidence-supported interventions) are indicated solely to facilitate measurable functional gains, e.g., improved range of motion, strength, positional tolerance, or work capacity, rather than as standalone or indefinite pain-relief measures. They form one time-limited component of a multimodal, goal-oriented plan that prioritizes early reactivation, psychosocial risk mitigation, and objective documentation of progress toward return to work or pre-injury function, consistent with ACOEM, state workers’ compensation guidelines, and CDC principles that condition continued treatment on demonstrated functional improvement.

Central role of return to work/prior functional status and causation analysis

Return to work (or equivalent prior functional status) is both a therapeutic goal and an outcome measure. Guidelines state that medical care should focus on restoring the ability to meet daily and work activities while returning the patient to pre-injury status insofar as feasible. Early, safe return, often with temporary restrictions, is associated with better physical, psychological, and economic outcomes. The longer a worker remains off work, the lower the probability of successful return; therefore, every visit addresses current work capacity, barriers, and a plan to advance function.

Equally critical is rigorous cause-and-effect evaluation. The trained pain specialist is optimally equipped to match the reported mechanism of injury against objective findings, imaging, and functional impairments. This matching process establishes (or refutes) medical causation, ensures that treatment targets the correctly attributed impairment, and provides the documentary foundation required for claims adjudication and appropriate care authorization.

In summary, evidence-based pain management in this population is optimized when performed by a pain specialist. Such evaluation incorporates meticulous functional and causation documentation (including explicit cause-and-effect matching of mechanism to impairment), prioritization of active rehabilitation and early return to productive activity, early attention to psychosocial risk factors, judicious and time-limited pharmacotherapy, and continuous measurement of objective functional progress rather than pain scores alone. These principles, drawn from ACOEM, CDC, state workers’ compensation guidelines, and related systematic evidence, optimize recovery while minimizing iatrogenic disability.

Kayvan Haddadan is a physiatrist and pain management physician, and president and medical director of Advanced Pain Diagnostic & Solutions, a multidisciplinary pain management practice in California that he founded in 2012. A physician and surgeon licensed by the Medical Board of California, he is double board-certified in pain medicine and physical medicine and rehabilitation. He is also certified in controlled substance registration through the DEA and serves as a qualified medical examiner through California’s Department of Industrial Relations Division of Workers’ Compensation.

Dr. Haddadan earned his Bachelor of Science degree from the College of Alborz in Tehran, Iran, and his medical degree from Shahid Beheshti University of Medical Sciences. He later received his Educational Commission for Foreign Medical Graduates certification in Philadelphia, completed an internship in medical surgery at Loyola University Medical Center’s Stritch School of Medicine in Illinois, and finished his residency in physical medicine and rehabilitation at the same institution. He completed his fellowship in pain medicine at California Pacific Medical Center’s Pacific Pain Treatment Center and also trained in medical acupuncture for physicians at the University of California, Los Angeles David Geffen School of Medicine.

Dr. Haddadan has contributed to 29 research publications across multiple specialties, including pain management, cardiology, pulmonology, endocrinology, gastroenterology, and infectious disease. His work has examined topics such as hyperlipidemia in high cardiovascular risk patients, hyperuricemia and gout management, type 2 diabetes and hypertension, chronic obstructive pulmonary disease and asthma therapies, influenza treatment, irritable bowel syndrome, and opioid related complications in chronic pain care. His research has also included clinical outcome studies in spinal cord stimulation and award-winning presentations on neuropathic pain management and neuromuscular disorders.